Cambridge Antibody, Drug Royalty, Inwest Investments Ltd. deal

Inwest offered to acquire DRI for C$3.05 in cash for each DRI share, valuing the deal at C$133 million (US$83.5 million). Under a January deal, DRI is being acquired by CAT for C$127 million (US$79.7 ...